• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA(lncRNAs)标志物在肾细胞癌中的作用。

The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.

机构信息

Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 113 Żeromskiego Street, 90-549 Lodz, Poland.

Department of Urology, Medical University of Lodz, 113 Żeromskiego Street, 90-549 Lodz, Poland.

出版信息

Int J Mol Sci. 2022 Dec 30;24(1):643. doi: 10.3390/ijms24010643.

DOI:10.3390/ijms24010643
PMID:36614082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9820502/
Abstract

Renal cell carcinoma is one of the common cancers whose incidence and mortality are continuously growing worldwide. Initially, this type of tumour is usually asymptomatic. Due to the lack of reliable diagnostic markers, one-third of ccRCC patients already have distant metastases at the time of diagnosis. This underlines the importance of establishing biomarkers that would enable the prediction of the disease's course and the risk of metastasis. LncRNA, which modulates genes at the epigenetic, transcriptional, and post-transcriptional levels, appears promising. The actions of lncRNA involve sponging and sequestering target miRNAs, thus affecting numerous biological processes. Studies have confirmed the involvement of RNAs in various diseases, including RCC. In this review, we focused on MALAT1 (a marker of serious pathological changes and a factor in the promotion of tumorigenesis), RCAT1 (tumour promoter in RCC), DUXAP9 (a plausible marker of localized ccRCC), TCL6 (exerting tumour-suppressive effects in renal cancer), LINC00342 (acting as an oncogene), AGAP2 Antisense1 (plausible predictor of RCC progression), DLEU2 (factor promoting tumours growth via the regulation of epithelial-mesenchymal transition), NNT-AS1 (sponge of miR-22 contributing to tumour progression), LINC00460 (favouring ccRCC development and progression) and Lnc-LSG1 (a factor that may stimulate ccRCC metastasis).

摘要

肾细胞癌是一种常见的癌症,其发病率和死亡率在全球范围内持续增长。最初,这种肿瘤通常没有症状。由于缺乏可靠的诊断标志物,三分之一的 ccRCC 患者在诊断时已经有远处转移。这凸显了建立生物标志物的重要性,这些标志物能够预测疾病的进程和转移的风险。lncRNA 在表观遗传、转录和转录后水平上调节基因,具有很大的应用前景。lncRNA 的作用包括海绵吸附和隔离靶 miRNAs,从而影响许多生物过程。研究已经证实 RNA 参与了包括 RCC 在内的各种疾病。在这篇综述中,我们重点介绍了 MALAT1(严重病理变化的标志物和促进肿瘤发生的因素)、RCAT1(RCC 的肿瘤促进剂)、DUXAP9(局部 ccRCC 的合理标志物)、TCL6(在肾癌中发挥肿瘤抑制作用)、LINC00342(作为癌基因)、AGAP2 Antisense1(RCC 进展的合理预测因子)、DLEU2(通过调节上皮-间充质转化促进肿瘤生长的因子)、NNT-AS1(miR-22 的海绵促进肿瘤进展)、LINC00460(有利于 ccRCC 发展和进展)和 Lnc-LSG1(可能刺激 ccRCC 转移的因素)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4550/9820502/30ab15d370a4/ijms-24-00643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4550/9820502/30ab15d370a4/ijms-24-00643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4550/9820502/30ab15d370a4/ijms-24-00643-g001.jpg

相似文献

1
The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.长链非编码 RNA(lncRNAs)标志物在肾细胞癌中的作用。
Int J Mol Sci. 2022 Dec 30;24(1):643. doi: 10.3390/ijms24010643.
2
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.长链非编码 RNA NNT-AS1 通过调节 miR-137/Y 盒结合蛋白 1 轴促进肾透明细胞癌的进展。
Bioengineered. 2021 Dec;12(1):8994-9005. doi: 10.1080/21655979.2021.1992330.
3
LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.长链非编码 RNA DNAJC3-AS1 通过调控 miR-27a-3p/PRDM14 轴在肾细胞癌中发挥癌基因作用。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1291-1301. doi: 10.26355/eurrev_202102_24833.
4
DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.DARS-AS1 通过隔离 miR-194-5p 来上调 DARS 促进肾透明细胞癌。
Biomed Pharmacother. 2020 Aug;128:110323. doi: 10.1016/j.biopha.2020.110323. Epub 2020 Jun 8.
5
Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.长链非编码 RNA PENG 通过海绵吸附 miR-15b 上调 PDZK1 表达,抑制肾透明细胞癌细胞增殖。
Oncogene. 2020 May;39(22):4404-4420. doi: 10.1038/s41388-020-1297-1. Epub 2020 Apr 27.
6
The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.长链非编码 RNA SNHG5 通过靶向 ZEB1 下调 miR-205-5p 促进肾透明细胞癌的进展。
Cancer Med. 2020 Jun;9(12):4251-4264. doi: 10.1002/cam4.3052. Epub 2020 Apr 12.
7
LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.长链非编码RNA TP73-AS1通过抑制KISS1表达及PI3K/Akt/mTOR信号通路失活促进透明细胞肾细胞癌的细胞增殖并抑制细胞凋亡。
Cell Physiol Biochem. 2018;48(1):371-384. doi: 10.1159/000491767. Epub 2018 Jul 17.
8
Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.长链非编码 RNA ZFPM2-AS1 通过靶向 miR-137 促进肾细胞癌的肿瘤发生。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5675-5681. doi: 10.26355/eurrev_201907_18304.
9
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.
10
Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.长链非编码 RNA ZFAS1 通过靶向 miR-10a/SKA1 通路促进肾透明细胞癌的增殖和转移。
Biomed Pharmacother. 2019 Mar;111:917-925. doi: 10.1016/j.biopha.2018.12.143. Epub 2019 Jan 7.

引用本文的文献

1
Clinical significance and regulatory mechanism of miR-134-5p in rheumatic heart disease.miR-134-5p在风湿性心脏病中的临床意义及调控机制
BMC Cardiovasc Disord. 2025 Aug 20;25(1):618. doi: 10.1186/s12872-025-05086-9.
2
Migrasome-related lncRNAs predict prognosis and immune response of clear cell renal cell carcinoma.与迁移小体相关的长链非编码RNA预测透明细胞肾细胞癌的预后和免疫反应。
Transl Androl Urol. 2025 May 30;14(5):1214-1229. doi: 10.21037/tau-2024-728. Epub 2025 May 27.
3
The prognostic and immune significance of in clear cell renal cell carcinoma.

本文引用的文献

1
Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma.鉴定与透明细胞肾细胞癌预后和转移相关的三种糖酵解相关lncRNA特征
Front Med (Lausanne). 2022 Jan 10;8:777507. doi: 10.3389/fmed.2021.777507. eCollection 2021.
2
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination.METTL14介导的Lnc-LSG1 m6A修饰通过调节ESRP2泛素化抑制肾透明细胞癌转移。
Mol Ther Nucleic Acids. 2021 Dec 17;27:547-561. doi: 10.1016/j.omtn.2021.12.024. eCollection 2022 Mar 8.
3
在透明细胞肾细胞癌中(此处英文不完整,可能影响准确理解,大致意思为)其预后及免疫意义。
Transl Cancer Res. 2025 Feb 28;14(2):1008-1023. doi: 10.21037/tcr-24-1509. Epub 2025 Feb 26.
4
A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma.一种新型的干性相关长链非编码RNA特征可预测透明细胞肾细胞癌的预后、免疫浸润和药物敏感性。
J Transl Med. 2025 Feb 27;23(1):238. doi: 10.1186/s12967-025-06251-6.
5
Innovative laboratory techniques shaping cancer diagnosis and treatment in developing countries.创新实验室技术正在塑造发展中国家的癌症诊断与治疗。
Discov Oncol. 2025 Feb 8;16(1):137. doi: 10.1007/s12672-025-01877-w.
6
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.长链非编码RNA TCL6通过调控miR-876-5p/MYL2轴抑制乳腺癌进展。
Transl Oncol. 2025 Mar;53:102210. doi: 10.1016/j.tranon.2024.102210. Epub 2025 Jan 27.
7
Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma.DBF4在肾透明细胞癌中的临床意义及促癌功能
BMC Urol. 2025 Jan 16;25(1):8. doi: 10.1186/s12894-025-01694-x.
8
The Emerging Role of Long Noncoding RNAs in Sorafenib Resistance Within Hepatocellular Carcinoma.长链非编码RNA在肝细胞癌索拉非尼耐药中的新作用
Cancers (Basel). 2024 Nov 21;16(23):3904. doi: 10.3390/cancers16233904.
9
Role of SLC7A11/xCT in Ovarian Cancer.SLC7A11/xCT 在卵巢癌中的作用。
Int J Mol Sci. 2024 Jan 2;25(1):587. doi: 10.3390/ijms25010587.
10
Biomarkers in renal cell carcinoma and their targeted therapies: a review.肾细胞癌中的生物标志物及其靶向治疗:综述
Explor Target Antitumor Ther. 2023;4(5):941-961. doi: 10.37349/etat.2023.00175. Epub 2023 Oct 25.
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.
AGAP2-AS1作为疾病进展的低风险透明细胞肾细胞癌患者的预后生物标志物。
Cancer Cell Int. 2021 Dec 20;21(1):690. doi: 10.1186/s12935-021-02395-9.
4
Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.长链非编码RNA DLEU2在肾透明细胞癌和肝细胞癌中的预后价值及其与免疫浸润的关系
Int J Gen Med. 2021 Nov 11;14:8047-8064. doi: 10.2147/IJGM.S336428. eCollection 2021.
5
Tumor extracellular vesicles drive metastasis (it's a long way from home).肿瘤细胞外囊泡驱动转移(这离家还远着呢)。
FASEB Bioadv. 2021 Aug 6;3(11):930-943. doi: 10.1096/fba.2021-00079. eCollection 2021 Nov.
6
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.长链非编码 RNA NNT-AS1 通过调节 miR-137/Y 盒结合蛋白 1 轴促进肾透明细胞癌的进展。
Bioengineered. 2021 Dec;12(1):8994-9005. doi: 10.1080/21655979.2021.1992330.
7
TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma.TBC1D3家族是一种预后生物标志物,与肾透明细胞癌中的免疫浸润相关。
Mol Ther Oncolytics. 2021 Jul 10;22:528-538. doi: 10.1016/j.omto.2021.06.014. eCollection 2021 Sep 24.
8
TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways.TET3 促进 AML 的生长,并通过表观遗传调控葡萄糖代谢和白血病干细胞相关通路。
Leukemia. 2022 Feb;36(2):416-425. doi: 10.1038/s41375-021-01390-3. Epub 2021 Aug 30.
9
LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs.LINC01140通过吸附多种微小RNA促进肺癌进展和肿瘤免疫逃逸。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-002746.
10
Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma.长链非编码RNA LINC00460的异常是一个有前景的预后因素,且与透明细胞肾细胞癌的进展相关。
Cancer Manag Res. 2021 Aug 16;13:6489-6497. doi: 10.2147/CMAR.S322747. eCollection 2021.